Bosh sahifaTHYROCARE • NSE
add
Thyrocare Technologies Ltd
Yopilish kursi
890,25 ₹
Kunlik diapazon
872,10 ₹ - 900,00 ₹
Yillik diapazon
571,40 ₹ - 1 055,00 ₹
Bozor kapitalizatsiyasi
46,25 mlrd INR
Oʻrtacha hajm
174,87 ming
Narx/foyda
51,35
Dividend daromadliligi
2,05%
Asosiy maydon
NSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,74 mlrd | 12,72% |
Joriy xarajat | 517,30 mln | 38,95% |
Sof foyda | 219,50 mln | 23,45% |
Sof foyda marjasi | 12,62 | 9,45% |
Har bir ulushga tushum | 4,16 | 17,51% |
EBITDA | 576,75 mln | 82,36% |
Amaldagi soliq stavkasi | 54,08% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,56 mlrd | 6,73% |
Jami aktivlari | 6,76 mlrd | 5,04% |
Jami passivlari | 1,39 mlrd | 19,78% |
Umumiy kapital | 5,37 mlrd | — |
Tarqatilgan aksiyalar | 52,64 mln | — |
Narxi/balansdagi bahosi | 8,72 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 20,54% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 219,50 mln | 23,45% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Tashkil etilgan
1996
Bosh ofis
Sayt
Xodimlar soni
1 693
